Company Filing History:
Years Active: 2006-2007
Title: Gianfranco Paradisi: Innovator in Hormone Purification
Introduction
Gianfranco Paradisi is a notable inventor based in Monterotondo, Italy. He has made significant contributions to the field of biochemistry, particularly in the purification processes of hormones. With a total of 2 patents, his work has advanced the methods used in the pharmaceutical industry.
Latest Patents
Paradisi's latest patents include a process for the purification of recombinant human Chorionic Gonadotropin (hCG) and a process for the purification of recombinant human Luteinizing Hormone (LH). The hCG purification process utilizes a combination of ion-exchange chromatography and reverse phase HPLC, performed twice, followed by size exclusion chromatography. This method results in a highly purified hCG with a specific bioactivity of about 25,000 IU/mg. Similarly, the LH purification process employs ion-exchange chromatography and reverse phase HPLC, also performed twice, culminating in purification through a gel permeation column. The purified LH obtained from this process exhibits a specific bioactivity of 25,000 IU/mg.
Career Highlights
Throughout his career, Gianfranco Paradisi has worked with prominent companies such as Applied Research Systems Ars Holding N.V. and Laboratoires Serono S.A. His expertise in hormone purification has been instrumental in enhancing the quality and efficacy of pharmaceutical products.
Collaborations
Paradisi has collaborated with notable professionals in his field, including Mara Rossi and Laura Scaglia. Their combined efforts have contributed to the advancement of purification techniques in biochemistry.
Conclusion
Gianfranco Paradisi's innovative work in hormone purification has made a significant impact on the pharmaceutical industry. His patents reflect a commitment to improving the quality of biopharmaceuticals, showcasing his expertise and dedication to scientific advancement.